Who
Todd D. Macko
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Impact BioMedical.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $51K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Mar 2026
- Last trade
- 27 Mar 2026
- Last filed
- 30 Mar 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Mar 2026filed 30 Mar 2026 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $24K43,400 at $0.5615 | filing |
| 27 Mar 2026filed 30 Mar 2026 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $24K43,400 at $0.56 | filing |
| 25 Mar 2026filed 30 Mar 2026 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $9611,600 at $0.6008 | filing |
| 25 Mar 2026filed 30 Mar 2026 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $9601,600 at $0.60 | filing |
News
No headline names them, or the companies they trade most, lately.